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Introduction {#sec001}
============

Inherited variation in the melanocortin-1 receptor (*MC1R*) gene is a robust genetic marker for moderately increased risk of melanoma \[[@pone.0119920.ref001]\]. We hypothesize that variation in *MC1R* influences the occurrence of melanomas that can be distinguished by histology or other tumor characteristics. However, evidence supporting a consistent association between *MC1R* variation and melanoma tumor characteristics is limited. Direct cross-study comparisons are hindered due in part to a lack of standardized measures and characterization of *MC1R* risk variants \[[@pone.0119920.ref002]\], coupled with differences in categorization of melanoma characteristics (*e*.*g*. collapsing of anatomic site presentation).

To more thoroughly address whether *MC1R* variants are associated with tumor characteristics, we present results from individuals diagnosed with a first incident primary tumor in a large population-based case-control study of melanoma: the Genes, Environment and Melanoma (GEM) Study. We examined associations between variation in *MC1R* and American Joint Committee on Cancer (AJCC) established tumor characteristics that are associated with prognosis: Breslow thickness and presence of mitoses and ulceration \[[@pone.0119920.ref003]--[@pone.0119920.ref008]\], as well as with presence of tumor infiltrating lymphocytes (TILs), a purported prognostic factor \[[@pone.0119920.ref009]\]. We also evaluated other histopathological tumor features for associations with *MC1R* variation in an effort to further characterize potential etiologic heterogeneity.

Materials and Methods {#sec002}
=====================

GEM Study {#sec003}
---------

The GEM Study is a population-based case-control study that enrolled a large series of individuals diagnosed with a first incident invasive primary cutaneous melanoma. Study participants were identified from eight population-based cancer registries and one hospital center in Australia, Canada, Italy and the United States. Detailed study recruitment methods have been previously described \[[@pone.0119920.ref010],[@pone.0119920.ref011]\]. The human research oversight committees at each of the GEM study sites, including those at the British Columbia Cancer Agency, Vancouver, BC, CA; Cancer Care Ontario, Toronto, ON, CA; Centro per la Prevenzione Oncologia, Torino, IT; Memorial Sloan Kettering Cancer Center, New York, NY, US; Menzies Cancer Center, Hobart, TAS, AU; University of California, Irvine, CA, US; University of Michigan, Ann Arbor, MI, US; University of North Carolina, Chapel Hill, NC, US; and University of Sydney, Sydney, NSW, AU, approved the study protocol. Written and signed informed consent was obtained from all participants.

Diagnostic pathology reports were obtained for each participant with a first incident primary melanoma (n = 2,424) from the appropriate ascertainment center, and data corresponding to histological subtype, lesion thickness, and anatomic location of lesion were abstracted. Tumor tissue slides for 2,105 (86.8%) participants with a diagnosis of first incident melanoma were available for centralized pathological review, performed in large part by one of three study pathologists (KB, LF, PG). Standardized pathologic review of slides included evaluation of: histologic subtype, Breslow thickness, Clark level, mitoses, solar elastosis, TILs, presence of satellite lesions, presence of coexisting nevi, presence of pigmentation, evidence of lesion regression, ulceration, and vertical growth phase. Melanomas were classified according to established histopathological criteria \[[@pone.0119920.ref012],[@pone.0119920.ref013]\]. Since Breslow thickness was both abstracted from the pathology report and recorded during the centralized pathologic review, the measure corresponding to the deepest reading was chosen to represent the value of most biological relevance.

Using a glossy colored guide to aid in differentiating between nevi and other skin lesions, participants were asked to have the nevi on their backs counted by a family member or friend; logistic models were adjusted for this continuous variable. A phenotypic index was derived using data collected from a study participant self-administered questionnaire \[[@pone.0119920.ref014]\], and was based on: hair color (black or dark brown = 1; light brown or blond = 2; red = 3), eye color (black or brown = 0; all other colors = 1), and relative inability to tan in response to sun exposure (no = 0; yes = 1) \[[@pone.0119920.ref015]\]. Phenotypic index scores of 1 and 2 indicate relatively darker cutaneous phenotypes and lower phenotypic melanoma risk; an index score of 3 indicates medium phenotypic risk. Hereinafter, we refer to individuals with any of these three scores as having a "sun-resistant" phenotype. Phenotypic index scores of 4 and 5 indicate relatively fairer cutaneous phenotypes and higher phenotypic risks for melanoma, hereinafter referred to as "sun sensitive".

MC1R Genotyping {#sec004}
---------------

Details of *MC1R* genotyping methods, distribution of observed *MC1R* variants, and variant carrier status among GEM Study participants have been described previously \[[@pone.0119920.ref015],[@pone.0119920.ref016]\]. We adopted nomenclature and definitions based on previous literature \[[@pone.0119920.ref001],[@pone.0119920.ref017]--[@pone.0119920.ref020]\] to classify *MC1R* variants as conferring higher risk for melanoma based on strong association with red hair phenotype \[R\] (D84E, R142H, R151C, R160W, and D294H, all nonsense and insertion/deletion) or lower risk for melanoma based on weaker association with red hair phenotype \[r\] (all other nonsynonymous variants). Since the exact functional status of many *MC1R* variants is still unknown, we acknowledge that these risk categories may be inaccurate. We categorized *MC1R* carriage into four groups: consensus (absence of any variants), only \[r\] (carriage of any \[r\] variant in the absence of a \[R\] variant), one \[R\] (carriage of a single \[R\] variant), and \>1 \[R\] (carriage of more than 1 \[R\] variant). Secondarily, we examined associations between *MC1R* variant carriage number and tumor characteristics by coding *MC1R* genotype based on total number of variants (\[r\] and \[R\]; 0 variants vs. 1 variant vs. 2 or more variants).

Statistical Analysis {#sec005}
--------------------

For this report, we include only those GEM participants with first incident primary melanomas who were successfully genotyped for *MC1R* and who self-reported their race as white (n = 2,160). We used SAS (SAS Institute, Cary, NC) to perform multinomial logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between *MC1R* variant status and tumor characteristics while adjusting for sex, age at most recent melanoma diagnosis, study ascertainment center, phenotypic index and number of nevi on the back. For tumor characteristics that were modeled dichotomously, results are equivalent to those obtained from a binomial logistic regression model. We also conducted analyses stratified by sun-resistant and sun-sensitive phenotypes; we then evaluated the Wald p-value of the interaction term for sun sensitivity by *MC1R* to assess heterogeneity of effect between sun-sensitive and sun-resistant phenotypes. All statistical tests were two-sided with an alpha level of 0.05.

Results {#sec006}
=======

Overall, tumor characteristics were not associated with genotyping success (data not shown). In univariate analyses, we compared the distributions of *MC1R* genotype risk categories across strata of prognostic tumor characteristics including: Breslow thickness and presence of mitoses, ulceration, or TILs. No statistically significant associations were noted among these tumor characteristics. We did observe a statistically significant association between anatomical site and *MC1R* variant carriage based on low-\[r\] and high-\[R\] risk variant carriage (p = 0.002) ([Table 1](#pone.0119920.t001){ref-type="table"}). Our findings with respect to *MC1R* variant carriage number were consistent with no association (data not tabulated).

10.1371/journal.pone.0119920.t001

###### Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between MC1R variants and histopathological tumor characteristics among first incident cases of invasive melanoma in the GEM Study.
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                                                                                                          Consensus   Only r[^1^](#t001fn003){ref-type="table-fn"}   One R[^2^](#t001fn004){ref-type="table-fn"}   \>1 R[^2^](#t001fn004){ref-type="table-fn"}   Only r[^1^](#t001fn003){ref-type="table-fn"} vs. consensus   One R[^2^](#t001fn004){ref-type="table-fn"} vs. consensus   \>1 R[^2^](#t001fn004){ref-type="table-fn"} vs. consensus                                                                 
  ------------------------------------------------------------------------------- ----------------------- ----------- ---------------------------------------------- --------------------------------------------- --------------------------------------------- ------------------------------------------------------------ ----------------------------------------------------------- ----------------------------------------------------------- ------ ------------- ------ ------------ ------ ------------- --
  **Breslow thickness (mm)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                  0.01--1.00              251         18                                             464                                           33                                            562                                                          40                                                          136                                                         10     1.00                 1.00                1.00          
  1.01--2.00                                                                      60                      14          141                                            33                                            181                                           43                                                           42                                                          10                                                          1.21   0.85--1.72    1.34   0.95--1.90   1.38   0.83--2.28    
  \>2.00                                                                          49                      17          103                                            33                                            107                                           37                                                           32                                                          11                                                          1.12   0.75--1.65    0.94   0.63--1.39   1.02   0.58--1.79    
                                                                                  p = 0.45                                                                                                                                                                                                                                                                                                                                                                                                                          
  **Mitoses**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                  Absent                  173         17                                             315                                           32                                            408                                                          41                                                          96                                                          10     1.00                 1.00                1.00          
  Present                                                                         120                     16          260                                            35                                            293                                           39                                                           81                                                          11                                                          1.06   0.79--1.43    1.01   0.76--1.36   1.16   0.76--1.78    
                                                                                  p = 0.56                                                                                                                                                                                                                                                                                                                                                                                                                          
  **Ulceration**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                  Absent                  267         17                                             526                                           33                                            636                                                          40                                                          158                                                         10     1.00                 1.00                1.00          
  Present                                                                         26                      17          47                                             31                                            61                                            40                                                           18                                                          12                                                          0.81   0.48--1.37    0.99   0.59--1.64   1.38   0.67--2.85    
                                                                                  p = 0.85                                                                                                                                                                                                                                                                                                                                                                                                                          
  **Tumor infiltrating lymphocytes** [^**†**^](#t001fn002){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                  Absent                  59          15                                             126                                           33                                            156                                                          41                                                          43                                                          11     1.00                 1.00                1.00          
  Non-brisk                                                                       197                     18          367                                            33                                            439                                           39                                                           112                                                         10                                                          0.89   0.61--1.30    0.93   0.64--1.34   1.09   0.63--1.87    
  Brisk                                                                           34                      15          79                                             34                                            100                                           43                                                           21                                                          9                                                           1.07   0.63--1.82    1.09   0.65--1.84   0.93   0.43--2.02    
                                                                                  p = 0.81                                                                                                                                                                                                                                                                                                                                                                                                                          
  **Anatomic location**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                  Trunk or pelvis         158         17                                             323                                           34                                            402                                                          42                                                          73                                                          8      1.00                 1.00                1.00          
  Head or neck                                                                    59                      18          123                                            36                                            131                                           39                                                           25                                                          7                                                           1.11   0.75--1.63    0.85   0.58--1.25   0.89   0.48--1.65    
  Arms                                                                            55                      14          137                                            34                                            157                                           39                                                           56                                                          14                                                          1.30   0.88--1.92    1.13   0.77--1.66   2.39   1.40--4.09    
  Legs                                                                            93                      20          138                                            30                                            174                                           38                                                           56                                                          12                                                          0.85   0.60--1.22    0.80   0.56--1.13   1.42   0.84--2.41    
                                                                                  p = 0.002                                                                                                                                                                                                                                                                                                                                                                                                                         
  **Clark level**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                  II                      120         17                                             234                                           33                                            294                                                          41                                                          73                                                          10     1.00                 1.00                1.00          
  III                                                                             94                      20          154                                            32                                            182                                           38                                                           48                                                          10                                                          0.79   0.56--1.12    0.74   0.53--1.05   0.72   0.43--1.21    
  IV & V                                                                          79                      15          185                                            34                                            222                                           41                                                           56                                                          10                                                          1.28   0.88--1.86    1.36   0.94--1.96   1.36   0.80--2.30    
                                                                                  p = 0.59                                                                                                                                                                                                                                                                                                                                                                                                                          
  **Coexisting nevus**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                  None identified         231         18                                             442                                           33                                            524                                                          40                                                          125                                                         10     1.00                 1.00                1.00          
  Common acquired                                                                 28                      12          77                                             32                                            102                                           42                                                           37                                                          15                                                          1.33   0.83--2.14    1.38   0.86--2.19   1.61   0.87--2.97    
  Dysplastic                                                                      35                      17          67                                             32                                            89                                            43                                                           17                                                          8                                                           0.87   0.54--1.38    0.98   0.62--1.54   0.96   0.48--1.93    
  Congenital                                                                      8                       24          11                                             33                                            11                                            33                                                           3                                                           9                                                           0.81   0.30--2.20    0.83   0.30--2.26   0.65   0.14--2.99    
                                                                                  p = 0.16                                                                                                                                                                                                                                                                                                                                                                                                                          
  **Histological type**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                  Superficial spreading   267         18                                             472                                           32                                            577                                                          40                                                          146                                                         10     1.00                 1.00                1.00          
  Nodular                                                                         21                      12          67                                             37                                            74                                            40                                                           21                                                          12                                                          1.61   0.98--2.74    1.45   0.85--2.45   1.58   0.77--3.26    
  Lentigo maligna                                                                 34                      17          66                                             33                                            80                                            40                                                           18                                                          9                                                           1.16   0.72--1.88    1.11   0.69--1.78   0.91   0.44--1.89    
  Not otherwise specified                                                         40                      15          98                                             36                                            112                                           42                                                           19                                                          7                                                           1.41   0.91--2.19    1.25   0.81--1.94   0.89   0.45--1.78    
                                                                                  p = 0.28                                                                                                                                                                                                                                                                                                                                                                                                                          
  **Pigmentation**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                  Present                 280         17                                             545                                           33                                            665                                                          40                                                          161                                                         10     1.00                 1.00                1.00          
  Absent                                                                          22                      14          53                                             33                                            67                                            41                                                           21                                                          13                                                          1.23   0.71--2.15    1.17   0.68--2.02   1.37   0.66--2.86    
                                                                                  p = 0.54                                                                                                                                                                                                                                                                                                                                                                                                                          
  **Regression**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                  Absent                  201         16                                             410                                           33                                            488                                                          40                                                          130                                                         11     1.00                 1.00                1.00          
  Present                                                                         101                     17          190                                            33                                            241                                           41                                                           52                                                          9                                                           1.10   0.79--1.54    1.19   0.86--1.65   0.95   0.58--1.56    
                                                                                  p = 0.73                                                                                                                                                                                                                                                                                                                                                                                                                          
  **Satellite**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                  Absent                  199         18                                             374                                           33                                            437                                                          39                                                          113                                                         10     1.00                 1.00                1.00          
  Present                                                                         1                       8           6                                              50                                            3                                             25                                                           2                                                           17                                                          2.30   0.26--20.15   0.77   0.07--8.80   1.36   0.07--26.83   
                                                                                  p = 0.57                                                                                                                                                                                                                                                                                                                                                                                                                          
  **Solar elastosis**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                  Absent                  105         17                                             206                                           33                                            263                                                          42                                                          60                                                          10     1.00                 1.00                1.00          
  Present                                                                         194                     17          378                                            33                                            453                                           40                                                           119                                                         10                                                          1.08   0.76--1.52    1.02   0.73--1.43   1.30   0.79--2.14    
                                                                                  p = 0.79                                                                                                                                                                                                                                                                                                                                                                                                                          
  **Vertical growth phase**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                  Absent                  106         17                                             207                                           33                                            249                                                          40                                                          60                                                          10     1.00                 1.00                1.00          
  Present                                                                         185                     17          364                                            33                                            450                                           40                                                           117                                                         11                                                          1.03   0.75--1.41    1.07   0.79--1.46   1.15   0.73--1.83    
                                                                                  p = 0.77                                                                                                                                                                                                                                                                                                                                                                                                                          

\* Row percentages are presented

^†^ Potential prognostic factor based on Thomas et al., J Clin Oncology, 2013. Vol. 33, Num. 33: 4252--59

^1^ r indicates carriage of V60L, V92M, I115T, R163Q, or rare nonsynonymous variants in the absence of a R variant.

^2^ R indicates carriage of D84E, R142H, R151C, R160W, D294H, nonsense or insertion/deletion variants.

^3^ ORs are adjusted for center, sex, age at melanoma diagnosis, phenotypic index, and total body mole density

Multivariate analyses are also presented in [Table 1](#pone.0119920.t001){ref-type="table"}. No statistically significant associations were noted among prognostic tumor characteristics. However, our adjusted analyses revealed a strong association between carriage of more than one *MC1R* \[R\] variant and melanoma development on the arms (OR = 2.39; 95% CI: 1.40, 4.09) when compared to individuals who developed melanomas on the trunk or pelvis. Associations between *MC1R* variants and strata of other melanoma tumor characteristics were consistent with no association after adjustment.

Because previous reports have indicated that melanoma risk associated with carriage of high-risk \[R\] *MC1R* variants is particularly informative among individuals with darker phenotypic characteristics \[[@pone.0119920.ref021]\], we explored associations between *MC1R* variants and the four prognostic tumor characteristics by skin pigmentation phenotype. We noted statistical heterogeneity between individuals with sun-sensitive and sun-resistant phenotypes for the associations between *MC1R* variants and Breslow thickness (p = 0.03), presence of mitoses (p = 0.03), presence of ulceration (p = 0.04), as well as presence of TILs (p = 0.01) ([Table 2](#pone.0119920.t002){ref-type="table"}). We observed relatively stronger associations between Breslow thickness and *MC1R* among sun-sensitive individuals. Similarly, we noted pronounced positive associations between carriage of only \[r\] variants (vs. carriage of only consensus) and presence of mitoses and ulceration among sun-sensitive individuals, whereas carriage of only \[r\] variants among sun-resistant participants showed little or no association with presence of mitoses and an inverse association with presence of ulceration. We found carriage of \[R\] variants was more prevalent among sun-sensitive individuals with non-brisk TILs observed in their melanomas compared to sun-resistant individuals with non-brisk TILs. In contrast, both \[r\] and \[R\] variants were more prevalent among sun-resistant cases with brisk TILs observed in their lesions compared to sun-sensitive cases with brisk TILs.

10.1371/journal.pone.0119920.t002

###### Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between MC1R variants and prognostic histopathological tumor characteristics among first incident cases of invasive melanoma in the GEM Study, stratified by phenotype.

![](pone.0119920.t002){#pone.0119920.t002g}

                                                                                               Phenotypically sun-sensitive[\*\*](#t002fn002){ref-type="table-fn"}   Phenotypically sun-resistant[^†^](#t002fn003){ref-type="table-fn"}   P~het~                                                                                                                                       
  ------------------------------------------------------------------------------- ------------ --------------------------------------------------------------------- -------------------------------------------------------------------- -------- ----- ----- ------ ------------- ------ ------------ ----- ----- ----- ----- ----- ----- ------ ------------ ------ ------------ -- ------
  **Breslow thickness (mm)**                                                                                                                                                                                                                                                                                                                                                           
                                                                                  0.01--1.00   48                                                                    12                                                                   87       21    273   67     1.00                 1.00               199   21    358   38    391   41     1.00                1.00            0.02
  1.01--2.00                                                                      7            6                                                                     26                                                                   21       88    73    2.05   0.76--5.53    2.38   0.96--5.92   51    18    109   38    126   44    1.10   0.75--1.60   1.18   0.81--1.73      
  \>2.00                                                                          12           11                                                                    37                                                                   35       57    54    1.61   0.74--3.50    0.73   0.35--1.52   35    20    61    36    75    44    0.97   0.97--1.54   1.13   0.72--1.78      
                                                                                  p = 0.01                                                                           p = 0.92                                                                                                                                                                                                          
  **Mitoses**                                                                                                                                                                                                                                                                                                                                                                          
                                                                                  Absent       36                                                                    12                                                                   59       20    199   68     1.00                 1.00               133   20    251   38    277   42     1.00                1.00            0.03
  Present                                                                         20           8                                                                     69                                                                   29       151   63    2.03   1.03--4.00    1.31   0.70--2.43   98    20    177   37    207   43    0.91   0.65--1.26   1.05   0.76--1.46      
                                                                                  p = 0.16                                                                           p = 0.99                                                                                                                                                                                                          
  **Ulceration**                                                                                                                                                                                                                                                                                                                                                                       
                                                                                  Absent       54                                                                    11                                                                   115      23    323   66     1.00                 1.00               208   20    397   38    430   42     1.00                1.00            0.04
  Present                                                                         2            5                                                                     13                                                                   32       26    63    3.17   0.67--15.03   1.89   0.42--8.51   23    23    29    28    50    49    0.60   0.33--1.08   0.98   0.57--1.67      
                                                                                  p = 0.64                                                                           p = 0.41                                                                                                                                                                                                          
  **Tumor infiltrating lymphocytes** [^**‡**^](#t002fn004){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                        
                                                                                  Absent       13                                                                    11                                                                   35       30    75    65     1.00                 1.00               44    18    85    35    113   47     1.00                1.00            0.01
  Non-brisk                                                                       31           9                                                                     72                                                                   21       233   69    0.81   0.36--1.84    1.53   0.72--3.24   162   22    285   38    300   40    0.95   0.62--1.45   0.78   0.51--1.18      
  Brisk                                                                           12           15                                                                    21                                                                   26       47    59    0.63   0.23--1.74    0.77   0.30--1.97   22    15    55    38    66    46    1.34   0.71--2.53   1.27   0.69--2.34      
                                                                                  p = 0.30                                                                           p = 0.43                                                                                                                                                                                                          

\* Row percentages are presented

\*\* Based on phenotypic index greater than 2

^†^ Based on phenotypic index less than or equal to 2

^‡^ Potential prognostic factor based on Thomas et al., J Clin Oncology, 2013. Vol. 33, Num. 33: 4252--59

^1^ r indicates carriage of V60L, V92M, I115T, R163Q, or rare nonsynonymous variants in the absence of a R variant.

^2^ R indicates carriage of D84E, R142H, R151C, R160W, D294H, nonsense or insertion/deletion variants.

^3^ ORs are adjusted for center, sex, age at melanoma diagnosis, and total body mole density

Discussion {#sec007}
==========

The GEM Study provides well-annotated histopathological data for melanomas and complete sequencing of participant DNA at the *MC1R* locus, which allows for a comprehensive examination of the associations between variants and histopathological tumor characteristics. In this study we report no pronounced or statistically significant main effect associations of *MC1R* with AJCC accepted prognostic factors of Breslow thickness, presence of ulceration, or presence of mitoses overall. Similarly, we did not observe an association between variation in *MC1R* and TILs, which were shown to be an important independent prognostic feature of melanoma in GEM \[[@pone.0119920.ref009]\].

However, we did find a persistent positive association between carriage of more than one \[R\] variant and melanoma presentation on the arms after adjustment. After stratification by skin pigmentation phenotype, this observed association was limited to individuals with sun-resistant phenotypes. There are several previous reports of *MC1R* variation in association with anatomical site of melanoma, but they generally grouped sites together on the basis of sun-exposure before analyses and/or categorized *MC1R* variants differently, \[[@pone.0119920.ref022]--[@pone.0119920.ref026]\] and are not directly comparable to this study. We did attempt to draw a comparison between our results and results from a case-control study of sporadic and familial melanoma in a Swedish population \[[@pone.0119920.ref025]\], which reported an increased association between carriage of ≥1 *MC1R* variant and melanoma presentation on the trunk (OR = 1.54; 95% CI: 1.01, 2.37). After recapitulating their coding for anatomic site, *MC1R*, and other covariates to the best of our ability, we were unable to replicate that finding (data not shown). Recently, Peña-Vilabelda *et*. *al*. reported results similar to our own with respect to high-risk *MC1R* variants in association with melanoma tumor site presentation (Arms: OR = 2.34; 95% CI: 0.98, 5.61) \[[@pone.0119920.ref027]\]. Interestingly, prior studies have noted more favorable prognoses among melanomas presenting on the extremities \[[@pone.0119920.ref028],[@pone.0119920.ref029]\]. Future studies of variation in *MC1R* related to anatomical melanoma presentation are necessary to validate our findings.

We explored effect modification by phenotypic index only among the prognostic measures of Breslow thickness, ulceration, mitoses, and TILs to limit the potential for false discovery. We observed significant differences between phenotypically sun-resistant and sun-sensitive individuals with respect to all four prognostic tumor factors. Interestingly, sun-sensitive cases demonstrated stronger associations across Breslow thickness, mitoses and ulceration compared to those observed among sun-resistant individuals. These results are thought-provoking considering that it is among individuals with more sun-resistant phenotypes that *MC1R* has been associated with increased risk for melanoma \[[@pone.0119920.ref021],[@pone.0119920.ref030]\]. However, we did note generally stronger associations between brisk TILs and *MC1R* among individuals with a sun-resistant phenotype compared to sun-sensitive cases. Although associations between *MC1R* variant carriage and all four prognostic variables were significantly different between phenotypic classifications, we were likely underpowered to detect associations within strata of phenotypic index despite the large sample size available in the GEM Study.

This investigation of tumor characteristics among 2,160 first incident cases of melanoma is the largest such study to examine associations with germline variation in *MC1R*. A strength of this study is the population-based nature of the parent GEM Study, from which a large number of incident cases were drawn from nine international ascertainment centers, improving generalizability of results to persons of European ancestry living in a variety of climates. Other advantages of this investigation were the centralized histopathological review conducted by expert pathologists and the ability to adjust for the potential impact of skin pigment and number of nevi. However, we do acknowledge the possibility that false positive findings may have arisen due to multiple hypothesis testing and the exploratory nature of associations examined between *MC1R* variation and tumor factors stratified by phenotypic index; thus, these findings should be validated in larger study populations before more meaningful interpretations can be made.
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